Federal Bid

Last Updated on 04 Jan 2019 at 9 AM
Special Notice
Location Unknown

mRNA Reagents

Solicitation ID W81XWH-19-Q-0028A
Posted Date 19 Dec 2018 at 3 PM
Archive Date 04 Jan 2019 at 5 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office U.S. Army Medical Research Acquisition Activity
Agency Department Of Defense
Location United states
The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of Walter Reed Army Institute of Research (WRAIR) intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with TriLink Biotech, 9955 Mesa Rim Road, San Diego, CA 92121, for the procurement of Messenger RNA (mRNA). Specifically, the government will establish a Blanket Purchase Agreement (BPA) to purchase the following items:

- PfCelTOS/Glyco-Mod Modified Bases mRNA, 5 mL Transcription scale Modified mRNA Transcript With Full Substitution of Pseudo-U and 5-Methyl-C Capped (Cap 1) using CleanCapTM AG Polyadenylated (120A) Dnase and Phosphatase Treatment Silica Membrane Purification Packaged as a solution in 1 mM Sodium Citrate, pH 6.4, including gene synthesis

- PfCelTOS/Glyco-Mod Modified Bases mRNA, 5 mL Transcription scale Unmodified mRNA Transcript Using Wild Type Bases Capped (Cap 1) using CleanCapTM AG Polyadenylated (120A) Dnase and Phosphatase Treatment Silica Membrane Purification Packaged as a solution in 1 mM Sodium Citrate, pH 6.4, including gene synthesis

- mRNA 1, 5 mL Transcription scale Unmodified mRNA Transcript Using Wild Type Bases Capped (Cap 1) using CleanCapTM AG Polyadenylated (120A) Dnase and Phosphatase Treatment Silica Membrane Purification Packaged as a solution in 1 mM Sodium Citrate, pH 6.4 , using template from previous synthesis

This requirement is for the synthesis and delivery of mRNA products in different quantities and different sequences as needed by WRAIR's Malaria Vaccine Branch (MVB). MVB will provide an mRNA sequence to the vendor who will synthesize that sequence and add stabilizing factors to both ends of the mRNA (at the 5' and 3' ends).

WRAIR has previously purchased mRNA from TriLink Biotech. They provided sequences to TriLink, which synthesized the sequence and added their own proprietary stabilizing factors. MVB does not have access to the sequences of these stabilizing factors and does not have their own stabilizing factors. If a different stabilizing factor sequence is used, it will void all research previously conducted using the TriLink mRNA.

The North American Industry Classification System (NAICS) for this requirement is 325413 and the size standard is 1,250 Employees.

This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Dawn Jennings at [email protected].


Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than 3:00 pm EST, Thursday, January 3, 2019.

Contracting Office Address:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014

Point of Contact:
Dawn Jennings

Bid Protests Not Available

Similar Past Bids

Location Unknown 11 Dec 2018 at 9 PM
Location Unknown 14 Jul 2009 at 4 PM
New hampshire 30 Jun 2015 at 2 AM
New hampshire 10 Jul 2015 at 2 PM
Natick Massachusetts 12 Apr 2021 at 1 PM

Similar Opportunities

Houston Texas 14 Jul 2025 at 7 PM
Houston Texas 14 Jul 2025 at 7 PM
Philadelphia Pennsylvania 30 Aug 2025 at 4 AM (estimated)
Washington District of columbia 06 Jul 2025 at 12 PM